RIYADH: The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO ADDWAEIH) has struck a deal with Swiss pharma giant Hoffmann La Roche to localize manufacturing of its immunosuppressive drug.

It represents the first complete localization in the Kingdom of manufacturing capacity for this type of advanced drug used to prevent the body from rejecting new organs after organ transplantation, the company said in a Saudi stock exchange listing.

The pharmaceuticals sector is a key part of the Kingdom's economic diversification plan as it aims for greater self-sufficiency in the manufacture of medicines and other medical products.

SPIMACOs pharmaceutical manufacturing facility is located in the industrial zone of Qassim, some 320 kilometers north west of Riyadh.

Copyright: Arab News © 2021 All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.